Lexaria Enters New Global Exclusive Collaboration and License Agreement with SulfoSyn
Global exclusivity for all non-pharmaceutical applications of DehydraTECH-sulforaphane has been awarded Minimum ongoing payments, royalties and manufacturing revenues part of the agreement KELOWNA, BC — Lexaria Bioscience Corp. (NASDAQ:LEXX) (NASDAQ:LEXXW) (the… Read More


